TELA
TELABio's Record-Breaking Q4: A Testament to Strategic Reinvention
Tela Bio, a leading player in the medical device industry, has reported a stellar fourth quarter and full year 2025 earnings performance. The company's strong commercial foundation, bolstered by strategic changes, has enabled it to achieve record revenues and drive durable growth. TELABio's CEO, Tony Koblish,